We further compared the clinicopathologic features and survival outcomes between breast cancers with MMR mutations (hereafter referred to as MMR-altered) and those with wild-type MMR (hereafter referred to as MMR-wt). This evidence concerns the gene MRC1 and breast carcinoma.